kidney disease

Kidney diseases such as IgA nephropathy, and drugs for them.

Theme · 2 companies · 0 report it as a revenue line

Show
8-K events
Match any selected event
8-K event types
More events

Only filters 8-Ks. Other selected forms stay visible.

  • ADRX ADARx Pharmaceuticals, Inc.

    In development“renal diseases, including IgAN, C3G and IC-MPGN”

    Latest 424B4final IPO prospectusPositivePre-revenue ·

    Develops siRNA drugs for hereditary angioedema and other diseases; $446M all-primary raise funds clinical development

  • VRTX Vertex Pharmaceuticals

    In development“Povetacicept’s IgAN application is under FDA priority review, with a November 30, 2026 PDUFA date; approval would give Vertex its first commercial nephrology product.”

    Latest 10-QQ3 FY2026Positive ·

    Crinetics adds an endocrine franchise, but deal costs and launch spending squeeze profit despite ALYFTREK-led sales growth.

    • Revenue$3.4BYoY +11.8%
    • Net income$653.6MYoY −39.6%

Feedback